Stockreport

Beyond Air halts sale of NeuroNOS subsidiary to XTL Biopharmaceuticals [Seeking Alpha]

Beyond Air, Inc.  (XAIR) 
PDF The companies had entered into a letter of intent in January 2026. The letter of intent expired on March 9, 2026, in accordance with its terms, and the parties did not [Read more]